CTNNB1 and cancer: To assess the performance of this screening platform, we began with β-catenin, a key hub in the Wnt signaling pathway that is an attractive intracellular target for therapeutic intervention in the many Wnt-driven cancers, such as those with APC or CTNNB1 mutations (29, 30).